by H.S. Ayoub
BioHealth Investor.com
Biotechnology
LPATH INC [LPTN.OB] +14.41%
HANA BIOSCIENCES INC [HNAB] +12.94%
NASTECH PHARM CO [NSTK] +10.86%
PIPEX PHARMACEUTICAL [PPXP.OB] +9.96%
ALFACELL CORP [ACEL] +8.98%
Diagnostic Substances
EPICEPT CORPORATION [EPCT] +73.25%
MONOGRAM BIOSCIENCES [MGRM] +11.06%
AVANT IMMUNOTHERAP [AVAN] +6.90%
PALATIN TECH INC [PTN] +4.66%
GENE LOGIC INC [GLGC] +4.57%
Drug Delivery
DELCATH SYSTEMS INC [DCTH] +6.84%
ALKERMES INC [ALKS] +2.91%
INSITE VISION INC [ISV] +2.60%
NEKTAR THERAPEUTIC [NKTR] +2.55%
NOVEN PHARMACEUTIC [NOVN] +2.35%
Drug Manufacturers
AVANIR PHARMACEUTICL [AVNR] +12.82%
POZEN INC [POZN] +7.32%
PROVECTUS PHARMA [PVCT.OB] +5.10%
OSCIENT PHARMACEUT [OSCI] +4.27%
JAVELIN PHARMACEUTIC [JAV] +3.52%
Drug Related Products
PRESTIGE BRAND HLGS [PBH] +4.41%
MANNATECH INC [MTEX] +1.85%
PACIFICHEALTH LABS [PHLI.OB] +1.74%
PERRIGO COMPANY [PRGO] +1.53%
LABOPHARM INC. [DDSS] +1.43%
Generic Drugs
CATALYST PHARMACEUTI [CPRX] +6.80%
ISOLAGEN INC [ILE] +1.74%
CARACO PHARMA LABS [CPD] +1.69%
WATSON PHARMACEUTCLS [WPI] +1.24%
HI-TECH PHARMACAL [HITK] +0.87%
Medical Appliances & Equipment
Supplies
NON INVASIVE MONITORNG SYS NEW [NIMU.OB] +9.93%
INTUITIVE SURG INC [ISRG] +8.71%
ALIGN TECHNOLOGY I [ALGN] +5.02%
NATUS MEDICAL INC [BABY] +4.50%
STEREOTAXIS, INC. [STXS] +4.11%
Medical Instruments & Supplies
VYTERIS HOLDINGS NV [VYHN.OB] +26.05%
ATRICURE, INC. [ATRC] +7.35%
BIOFORCE NANOSCIENCE [BFNH.OB] +4.90%
CRYOCOR, INC. [CRYO] +4.79%
KENSEY NASH CP [KNSY] +4.57%
Medical Laboratories & Research
SPHERIX INC [SPEX] +4.51%
MEDTOX SCIENTFIC INC [MTOX] +3.07%
OSI PHARMACEUTIC [OSIP] +2.18%
BIO-REFERENCE LAB [BRLI] +2.14%
ENZO BIOCHEM INC [ENZ] +1.24%
http://www.biohealthinvestor.com/
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.